Cemiplimab Granted Priority Review for Advanced NSCLC
Topline results from the trial showed that compared with chemotherapy, treatment with cemiplimab-rwlc reduced the risk of death by 32% in the overall trial population.
Topline results from the trial showed that compared with chemotherapy, treatment with cemiplimab-rwlc reduced the risk of death by 32% in the overall trial population.
Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.
Annual mammography screening, used by most patients, yields smaller and less advanced cancers.
A prospective study was conducted to determine the effectiveness of palliative sedation for patients with terminal illnesses who experience refractory symptoms.
In this evaluation of palliative care use, investigators were able to determine how the focus of palliative care – coping, treatment, or advanced care planning – influenced patients’ decisions on quality of life and decisions regarding chemotherapy and hospice care at the end of life.
Results of a nonblinded study demonstrate the value of incorporating early palliative care into oncologic care for patients with advanced cancer.
Researchers sought to determine the link between opioid use among patients with advanced cancer and health care use such as urgent care, inpatient, and emergency room visits.
An analysis of select responses to a survey conducted by researchers from the College of Nursing at South Dakota State University identified oncology nurses’ comfort level in handling end-of-life care and patient education.
In a prospective study, researchers assessed survival and quality of life measures for patients with advanced cancer in relation to where they are discharged from hospital: postacute care (PAC), hospice, or home without hospice.
Previous studies have shown that patients with advanced cancer may experience some financial relief integrating palliative care with standard oncologic care, but these results were coincidental findings and have not yet been fully explored.